MetLife Investment Management, LLC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 73 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$233,109
-58.2%
6,128
+0.0%
0.00%
-50.0%
Q2 2023$558,079
-82.8%
6,126
-87.5%
0.00%
-83.3%
Q1 2023$3,236,987
+26.0%
49,075
-1.2%
0.02%
+20.0%
Q4 2022$2,568,177
-24.3%
49,6650.0%0.02%
-31.0%
Q3 2022$3,392,120
+58.8%
49,665
+5.1%
0.03%
+70.6%
Q2 2022$2,136,057
+1.8%
47,237
+14.4%
0.02%
+21.4%
Q1 2022$2,098,097
+79.5%
41,293
+67.0%
0.01%
+40.0%
Q4 2021$1,169,045
+46.6%
24,726
+2.2%
0.01%
+42.9%
Q3 2021$797,599
-47.8%
24,1990.0%0.01%
-53.3%
Q2 2021$1,529,377
+47.3%
24,1990.0%0.02%
+50.0%
Q1 2021$1,038,379
-25.0%
24,1990.0%0.01%
-28.6%
Q4 2020$1,384,183
+71.5%
24,199
-9.5%
0.01%
+55.6%
Q3 2020$807,078
-7.6%
26,7510.0%0.01%
-10.0%
Q2 2020$873,688
+28.6%
26,751
+5.5%
0.01%0.0%
Q1 2020$679,502
-0.5%
25,364
+13.8%
0.01%
+42.9%
Q4 2019$682,673
+27.1%
22,2950.0%0.01%
+16.7%
Q3 2019$537,087
-4.9%
22,2950.0%0.01%0.0%
Q2 2019$564,953
+67.5%
22,295
+28.9%
0.01%
+50.0%
Q1 2019$337,311
+47.8%
17,2980.0%0.00%
+33.3%
Q4 2018$228,161
-25.8%
17,2980.0%0.00%0.0%
Q3 2018$307,558
+144.1%
17,298
+202.6%
0.00%
+200.0%
Q1 2018$126,0005,7160.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders